Stockhub

Fresh Tracks Therapeutics, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

27 September 2022

  • curprev 01:2901:29, 27 September 2022 95.149.241.133 talk 1,146 bytes +1,146 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatm..."
Retrieved from "https://stockhub.co/research/Fresh_Tracks_Therapeutics,_Inc."